A Conversation With the New MetrioPharm CFO Sven Zimmermann
You have been working in the life science and healthcare sector for more than fifteen years. What makes this work so appealing?
The sector has its own special challenges. On the one hand, the costs for drug development are significant and the development itself is highly regulated...
